MyFinsight
Home
Blog
About
Protagenic Therapeutics, Inc. new (PTIXW)
Protagenic Therapeutics, Inc. new (PTIXW)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$2,788,067
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from exercise of warran...
Change in fair value of derivati...
Cash received in acquisition of ...
Others
Negative Cash Flow Breakdown
Net loss
Accounts payable
Prepaid expenses
Inventories
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
Net loss
-5,927,019
Amortization of debt discount to interest expense
243,353
Stock based compensation
230,995
Derivative expense
-343,399
Change in fair value of derivative liabilities
-1,930,245
Depreciation expense
25,143
Increase in note payable for acquisition of phytanix bio
583,880
Inventories
37
Prepaid expenses
3,838
Vat receivable
-29,481
Accounts payable
-177,180
Accrued liabilities
158,912
Net cash used in operating activities
-2,562,666
Cash received in acquisition of phytanix bio
-943,180
Net cash provided by investing activities
943,180
Proceeds from sale of common stock
395,474
Proceeds from exercise of warrants
3,949,732
Proceeds from related party loans
62,347
Net cash provided by financing activities
4,407,553
Net increase in cash
2,788,067
Effect of exchange rate changes on cash
-80,147
Cash and cash equivalents at beginning of period
14,531
Cash and cash equivalents at end of period
2,722,451
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from exercise of
warrants
$3,949,732
Proceeds from sale of
common stock
$395,474
Proceeds from related
party loans
$62,347
Cash received in
acquisition of phytanix bio
-$943,180
Net cash provided by
financing activities
$4,407,553
Net cash provided by
investing activities
$943,180
Net increase in cash
$2,788,067
Canceled cashflow
$2,562,666
Change in fair value of
derivative liabilities
-$1,930,245
Increase in note payable
for acquisition of...
$583,880
Derivative expense
-$343,399
Amortization of debt discount
to interest...
$243,353
Stock based
compensation
$230,995
Accrued liabilities
$158,912
Vat receivable
-$29,481
Depreciation expense
$25,143
Net cash used in
operating activities
-$2,562,666
Canceled cashflow
$3,545,408
Net loss
-$5,927,019
Accounts payable
-$177,180
Prepaid expenses
$3,838
Inventories
$37
Buy us a coffee